- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04154345
Exercise Into Pain in Chronic Rotator Cuff Related Shoulder Pain: a Prospective Single-Group Feasibility Study
June 4, 2025 updated by: Filip Struyf, Universiteit Antwerpen
The purpose of this study is to evaluate a) the feasibility of applying a painful exercise program in the treatment of subacromial shoulder pain and b) the time needed to collect clinical outcomes for a future randomized controlled trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Exercise therapy is the first choice of treatment in the management of subacromial shoulder pain (SSP).
Guidelines suggest active rehabilitation program for at least three months and existing research highlights the importance of progressive loaded exercise therapy at higher dosage.
However, it is not clear which is the best type of exercise and if pain should be provoked during exercise.
Recent research found that painful exercises are beneficial in short term on pain and function in patients with different kinds of chronic musculoskeletal pain.
The aim of the future randomized clinical trial is to investigate if "exercising into pain" gives better results in term of clinical outcomes compared to a non-painful exercise program.
Since the intervention consists in painful exercises, it is essential to test the rate of adherence in the intervention group (both during physiotherapist-led session and home-based exercises).
Moreover, the practicability of clinical questionnaire via online survey will be tested and the time needed to collect clinical data will be calculated as well.
Furthermore, feedback from physiotherapists and participants will be collected and analyzed.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Antwerp, Belgium
- Physiotherapy private practices
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-65 years
- Shoulder pain for at least 3 months
- Pain in the antero-lateral shoulder region
- At least 3 out of 5 of the following tests positive: Neer test, Hawkins-Kennedy, Jobe, painful arc between 60° and 120°, external resistance test
- Resting pain should be at 2/10 maximum on verbal NRS scale
- All types of occupations were included: students, workers (including overhead workers or heavy duty workers), people on sick leave and retired people
Exclusion Criteria:
- Bilateral shoulder pain
- Corticosteroid injections 6 weeks prior to the study
- Pregnancy, inability to understand spoken or written Dutch
- Clinical signs of full-thickness rotator cuff tears (positive external and internal rotation lag tests and drop arm test)
- Evidence of adhesive capsulitis (50% or more than 30° loss of passive external rotation)
- Previous cervical, thoracic or shoulder surgery; recent fractures or dislocations on the painful shoulder
- Symptoms of cervical radiculopathy as primary complaint (tingling, radiating pain in the arm associated with neck complaints)
- Primary diagnosis of acromioclavicular pathology, shoulder instability
- A radiologically confirmed fracture or presence of calcification larger than 5 mm
- Presence of competing pathologies (inflammatory arthritis, neurological disorders, fibromyalgia, malignancy)
- More than 4h of training in sport overhead shoulder activities per week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Painful exercises
The pain allowed during exercises ranges between 4 and 7 on NPRS (Numeric Pain Rating Scale)
|
The intervention consists of 12 weeks of progressive loaded exercises, three times per week.
There are 9 sessions of supervised physiotherapy treatment, lasting 30 minutes, while the rest of the sessions is conducted as home exercises.
There are 4 strengthening exercises, in which the pain allowed ranges between 4 and 7 on a verbal NPRS for 9 weeks, then pain ratings are 0-2 for the remaining 3 weeks.
Every physiotherapy session includes also 15 minutes of manual therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Adherence (Physiotherapy Session)
Time Frame: measurement every session, final measure at the end of 12 weeks
|
It is analysed in terms of attendance to the physiotherapist-led sessions.
Good level of adherence is defined by attendance of 7/9 (78%) of physiotherapist led-sessions
|
measurement every session, final measure at the end of 12 weeks
|
|
Rate of Adherence (Adherence Home Exercises)
Time Frame: measurement every home exercise session, final measure at the end of 12 weeks
|
It is analysed in terms of adherence to home exercises.
Good level of adherence is achieved when patients completed at least 22 of 27 (81%) sessions.
One session of non-supervised (home) exercise was considered completed when at least 80% of the total amount of sets and repetitions were executed as prescribed by the physiotherapist.
|
measurement every home exercise session, final measure at the end of 12 weeks
|
|
Shoulder Pain and Disability Index (SPADI)
Time Frame: value at baseline minus value at 12 weeks
|
There are 13 items, divided in two subscales: pain (5 items) and function (8 items).
Each item is scored from 0 (no pain/no difficulty) to 10 (worst imaginable pain/so difficult it requires help) on a NPRS.
The final score is a percentage derived from an average of the two subscales, where higher score means worse outcome.
|
value at baseline minus value at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fear-Avoidance Beliefs Questionnaire (FABQ-PA)
Time Frame: value at baseline minus value at 12 weeks
|
Fear-Avoidance Beliefs Questionnaire, Subscale Physical Activity (range: 0-24) Higher scores indicate higher fear-avoidance beliefs
|
value at baseline minus value at 12 weeks
|
|
Fear-Avoidance Beliefs Questionnaire (FABQ-W)
Time Frame: value at baseline minus value at 12 weeks
|
Fear-Avoidance Beliefs Questionnaire, Subscale Work (range: 0-42) Higher scores indicate higher fear-avoidance beliefs
|
value at baseline minus value at 12 weeks
|
|
Fear of Pain Questionnaire (FPQ-9)
Time Frame: value at baseline minus value at 12 weeks
|
It is a shortened version of the Fear of Pain Questionnaire-III. The total score ranges between 9 and 45. Higher scores indicate more fear and anxiety associated with pain. |
value at baseline minus value at 12 weeks
|
|
Passive Range of Motion (ROM) in External Rotation
Time Frame: value at 12 weeks minus baseline
|
It is measured with the inclinometer.
The unit of measure is degrees.
Higher values indicate higher ROM.
|
value at 12 weeks minus baseline
|
|
Passive ROM in Internal Rotation
Time Frame: value at 12 weeks minus baseline
|
It is measured with the inclinometer.
The unit of measure is degrees.
Higher values indicate higher ROM.
|
value at 12 weeks minus baseline
|
|
Passive ROM in Scaption
Time Frame: value at 12 weeks minus baseline
|
It is measured with the inclinometer.
The unit of measure is degrees.
Higher values indicate higher ROM.
|
value at 12 weeks minus baseline
|
|
Active ROM in External Rotation
Time Frame: value at 12 weeks minus baseline
|
It is measured with the inclinometer.
The unit of measure is degrees.
Higher values indicate higher ROM.
|
value at 12 weeks minus baseline
|
|
Active ROM in Internal Rotation
Time Frame: value at 12 weeks minus baseline
|
It is measured with the inclinometer.
The unit of measure is degrees.
Higher values indicate higher ROM.
|
value at 12 weeks minus baseline
|
|
Active ROM in Scaption
Time Frame: value at 12 weeks minus baseline
|
It is measured with the inclinometer.
The unit of measure is degrees.
Higher values indicate higher ROM.
|
value at 12 weeks minus baseline
|
|
Maximum Voluntary Contraction (MVC) in External Rotation
Time Frame: value at 12 weeks minus value at baseline
|
It is measured with the hand-held dynamometer.
The unit of measure is Newtons.
Higher values indicate greater strength.
|
value at 12 weeks minus value at baseline
|
|
MVC in Internal Rotation
Time Frame: values at 12 weeks minus values at baseline
|
It is measured with the hand-held dynamometer.
The unit of measure is Newtons.
Higher values indicate greater strength.
|
values at 12 weeks minus values at baseline
|
|
MVC in Scaption
Time Frame: values at 12 weeks minus baseline
|
It is measured with the hand-held dynamometer.
The unit of measure is Newtons.
Higher values indicate greater strength.
|
values at 12 weeks minus baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acromiohumeral Distance (AHD)
Time Frame: value at baseline minus value at 12 weeks
|
It is measured with the Ultrasound machine at rest and at 60 degrees of elevation in the scapular plane.
(in millimeters)
|
value at baseline minus value at 12 weeks
|
|
Supraspinatus Tendon Thickness (STT)
Time Frame: value at baseline minus value at 12 weeks
|
It is measured with the Ultrasound machine in the Crass position (in millimeters)
|
value at baseline minus value at 12 weeks
|
|
Global Perceived Effect - Recovery (GPE-R)
Time Frame: value at baseline minus value at 12 weeks
|
The Global Perceived Effect (GPE) of recovery was measured after 1 week of treatment, at 6 week and at 12 weeks with the question: "To what extent do you feel recovered compared to the beginning of the treatment?"
(from 1=very much better to 7=very much worse).
Higher scores indicate worse outcome.
|
value at baseline minus value at 12 weeks
|
|
Global Perceived Effect - Satisfaction (GPE-S)
Time Frame: value at baseline minus value at 12 weeks
|
The Global Perceived Effect (GPE) of satisfaction was measured after 1 week of treatment, at 6 week and at 12 weeks with the question "To what extend are you satisfied about your treatment?"
(from 1=absolutely satisfied to 7=absolutely dissatisfied).
Higher scores indicate worse outcome.
|
value at baseline minus value at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Filip Struyf, Professor, Universiteit Antwerpen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 28, 2019
Primary Completion (Actual)
May 14, 2020
Study Completion (Actual)
May 14, 2020
Study Registration Dates
First Submitted
October 25, 2019
First Submitted That Met QC Criteria
November 4, 2019
First Posted (Actual)
November 6, 2019
Study Record Updates
Last Update Posted (Actual)
June 24, 2025
Last Update Submitted That Met QC Criteria
June 4, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18/34/379
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Impingement Syndrome
-
Lokman Hekim UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Rotator Cuff Impingement SyndromeTurkey (Türkiye)
-
China Medical University HospitalNot yet recruiting
-
California State University, Long BeachEnrolling by invitationSubacromial Impingement Syndrome | Rotator Cuff Syndrome | Apical Shoulder PainUnited States
-
Mahidol UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Subacromial Pain Syndrome | Subacromial Impingement | Impingement Syndrome, ShoulderIndonesia
-
Cairo UniversityCompletedSubacromial Impingement Syndrome | Shoulder Bursitis | Pilates ExerciseEgypt
-
Copenhagen University Hospital, HvidovreUniversity of Copenhagen; Aalborg University; Metropolitan University CollegeCompletedSubacromial Impingement SyndromeDenmark
-
Cairo UniversityRecruitingSubacromial Impingement SyndromeEgypt
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedSubacromial Impingement SyndromeTurkey (Türkiye)
-
Near East University, TurkeyCompletedSubacromial Impingement SyndromeCyprus
-
Hadassah Medical OrganizationUnknownShoulder Impingement Syndrome.
Clinical Trials on Exercise therapy (exercising into pain)
-
Universiteit AntwerpenUniversity of Southern Denmark; University of Malaga; Rotterdam University of...Completed
-
Hugo de Luca CorreaFederal University of São Paulo; Catholic University of BrasíliaCompletedQuality of Life | Inflammation | Muscle Weakness | Chronic Kidney Failure | Solid Organ Transplant Rejection
-
AURA SanteUnknownEnd Stage Renal Disease on Hemodialysis
-
University of DelawareCompletedJumper's Knee | Patellar Tendinopathy | Patellar Tendinitis | Patellar Tendon Pain | Patellar TendinosisUnited States
-
Vrije Universiteit BrusselRotterdam University of Applied SciencesRecruiting
-
Gulf Medical UniversityCompletedSubacromial Pain SyndromeUnited Arab Emirates
-
Centro Universitario La SalleUniversidad Rey Juan CarlosTerminatedChronic Pain | Neck PainSpain
-
University of Central LancashireRecruitingIntermittent ClaudicationUnited Kingdom
-
Universidad de GranadaCompletedChronic Low-back PainSpain